The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Omid,Rezahosseini

第一单位： a Cancer Immunology Project (CIP) , Universal Scientific Education and Research Network (USERN) , Tehran , Iran.

作者： Omid,Rezahosseini ^[1] ; Sara,Hanaei ^[2] ; Mehdi,Hamadani ^[1] ; Mahsa,Keshavarz-Fathi ^[3] ; Nima,Rezaei ^[4]

作者单位： a Cancer Immunology Project (CIP) , Universal Scientific Education and Research Network (USERN) , Tehran , Iran. ^[1] b Department of Infectious and Tropical diseases , Imam Khomeini Hospital Complex, Tehran University of Medical Sciences , Tehran , Iran. ^[2] c Research Center for Immunodeficiencies , Children's Medical Center, Tehran University of Medical Sciences , Tehran , Iran. ^[3] d School of Medicine , Tehran University of Medical Sciences , Tehran , Iran. ^[4] e Division of Hematology & Oncology , Medical College of Wisconsin , Milwaukee , WI , USA. ^[5] f Cancer Immunology Project (CIP) , Universal Scientific Education and Research Network (USERN) , Milwaukee , WI , USA. ^[6] g Students' Scientific Research Center , Tehran University of Medical Sciences , Tehran , Iran. ^[7] h Department of Immunology, School of Medicine , Tehran University of Medical Sciences , Tehran , Iran. ^[8] i Cancer Immunology Project (CIP) , Universal Scientific Education and Research Network (USERN) , Sheffield , UK. ^[9]

关键词 HIV-associated non-Hodgkin lymphoma human immunodeficiency virus immunotherapy monoclonal antibodies neoplasm rituximab